Home > Publications database > Genome-wide interaction analysis of folate for colorectal cancer risk. > print

001     282365
005     20240229155040.0
024 7 _ |a 10.1016/j.ajcnut.2023.08.010
|2 doi
024 7 _ |a pmid:37640106
|2 pmid
024 7 _ |a 0095-9871
|2 ISSN
024 7 _ |a 0002-9165
|2 ISSN
024 7 _ |a 1938-3207
|2 ISSN
024 7 _ |a 1938-3215
|2 ISSN
024 7 _ |a altmetric:153410945
|2 altmetric
037 _ _ |a DKFZ-2023-01747
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Bouras, Emmanouil
|b 0
245 _ _ |a Genome-wide interaction analysis of folate for colorectal cancer risk.
260 _ _ |a Oxford
|c 2023
|b Oxford University Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1699347352_10416
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2023 Nov;118(5):881-891
520 _ _ |a Epidemiological and experimental evidence suggests that higher folate intake is associated with a decreased colorectal cancer (CRC) risk; however, the mechanisms underlying this relationship are not fully understood. Genetic variation that may have a direct or indirect impact on folate metabolism can provide insights into folate's role in CRC.Our aim was to perform a genome-wide interaction analysis to identify genetic variants that may modify the association of folate on CRC risk.We applied traditional case-control logistic regression, joint 3-degree of freedom (3DF), and a two-step weighted hypothesis approach to test the interactions of common variants (allele frequency >1%) across the genome and dietary folate, folic acid supplement use, and total folate in relation to risk of CRC, in 30,550 cases and 42,336 controls from 51 studies from 3 genetic consortia (CCFR, CORECT, GECCO).Inverse associations of dietary, total folate, and folic acid supplement with CRC were found [odds ratio: 0.93 (95% confidence intervals [CI]: 0.90-0.96), and 0.91 (0.89-0.94) per quartile higher intake, and 0.82 (0.78-0.88) for users vs. non-users, respectively]. Interactions (P-interaction <5×10-8) of folic acid supplement and variants in the 3p25.2 locus [in the region of Synapsin II (SYN2)/tissue inhibitor of metalloproteinase 4 (TIMP4)] were found using the traditional interaction analysis, with variant rs150924902 (located upstream to SYN2) showing the strongest interaction. In stratified analyses by rs150924902 genotypes, folate supplement was associated with decreased CRC risk among those carrying the TT genotype (OR = 0.82; 95%CI: 0.79-0.86) but increased CRC risk among those carrying the TA genotype (OR = 1.63; 95%CI: 1.29-2.05), suggesting a qualitative interaction (P-interaction = 1.4×10-8). No interactions were observed for dietary and total folate.Variation in 3p25.2 locus may modify the association of folate supplement with CRC risk. Experimental studies and studies incorporating other relevant -omics data are warranted to validate this finding.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a CRC
|2 Other
650 _ 7 |a European
|2 Other
650 _ 7 |a GWIS
|2 Other
650 _ 7 |a SYN2
|2 Other
650 _ 7 |a TIMP4
|2 Other
650 _ 7 |a colorectal cancer
|2 Other
650 _ 7 |a folate
|2 Other
650 _ 7 |a folic acid
|2 Other
650 _ 7 |a genome-wide
|2 Other
650 _ 7 |a interaction
|2 Other
650 _ 7 |a synapsin
|2 Other
650 _ 7 |a tissue inhibitor of metalloproteinase 4
|2 Other
700 1 _ |a Kim, Andre E
|b 1
700 1 _ |a Lin, Yi
|b 2
700 1 _ |a Morrison, John
|b 3
700 1 _ |a Du, Mengmeng
|b 4
700 1 _ |a Albanes, Demetrius
|b 5
700 1 _ |a Barry, Elizabeth L
|b 6
700 1 _ |a Baurley, James W
|b 7
700 1 _ |a Berndt, Sonja I
|b 8
700 1 _ |a Bien, Stephanie A
|b 9
700 1 _ |a Bishop, Timothy D
|b 10
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 11
|u dkfz
700 1 _ |a Budiarto, Arif
|b 12
700 1 _ |a Burnett-Hartman, Andrea
|b 13
700 1 _ |a Campbell, Peter T
|b 14
700 1 _ |a Carreras-Torres, Robert
|b 15
700 1 _ |a Casey, Graham
|b 16
700 1 _ |a Cenggoro, Tjeng Wawan
|b 17
700 1 _ |a Chan, Andrew T
|b 18
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 19
|u dkfz
700 1 _ |a Conti, David V
|b 20
700 1 _ |a Cotterchio, Michelle
|b 21
700 1 _ |a Devall, Matthew
|b 22
700 1 _ |a Diez-Obrero, Virginia
|b 23
700 1 _ |a Dimou, Niki
|b 24
700 1 _ |a Drew, David A
|b 25
700 1 _ |a Figueiredo, Jane C
|b 26
700 1 _ |a Giles, Graham G
|b 27
700 1 _ |a Gruber, Stephen B
|b 28
700 1 _ |a Gunter, Marc J
|b 29
700 1 _ |a Harrison, Tabitha A
|b 30
700 1 _ |a Hidaka, Akihisa
|b 31
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 32
|u dkfz
700 1 _ |a Huyghe, Jeroen R
|b 33
700 1 _ |a Joshi, Amit D
|b 34
700 1 _ |a Kawaguchi, Eric S
|b 35
700 1 _ |a Keku, Temitope O
|b 36
700 1 _ |a Kundaje, Anshul
|b 37
700 1 _ |a Le Marchand, Loic
|b 38
700 1 _ |a Lewinger, Juan Pablo
|b 39
700 1 _ |a Li, Li
|b 40
700 1 _ |a Lynch, Brigid M
|b 41
700 1 _ |a Mahesworo, Bharuno
|b 42
700 1 _ |a Männistö, Satu
|b 43
700 1 _ |a Moreno, Victor
|b 44
700 1 _ |a Murphy, Neil
|b 45
700 1 _ |a Newcomb, Polly A
|b 46
700 1 _ |a Obón-Santacana, Mireia
|b 47
700 1 _ |a Ose, Jennifer
|b 48
700 1 _ |a Palmer, Julie R
|b 49
700 1 _ |a Papadimitriou, Nikos
|b 50
700 1 _ |a Pardamean, Bens
|b 51
700 1 _ |a Pellatt, Andrew J
|b 52
700 1 _ |a Peoples, Anita R
|b 53
700 1 _ |a Platz, Elizabeth A
|b 54
700 1 _ |a Potter, John D
|b 55
700 1 _ |a Qi, Lihong
|b 56
700 1 _ |a Qu, Conghui
|b 57
700 1 _ |a Rennert, Gad
|b 58
700 1 _ |a Ruiz-Narvaez, Edward
|b 59
700 1 _ |a Sakoda, Lori C
|b 60
700 1 _ |a Schmit, Stephanie L
|b 61
700 1 _ |a Shcherbina, Anna
|b 62
700 1 _ |a Stern, Mariana C
|b 63
700 1 _ |a Su, Yu-Ru
|b 64
700 1 _ |a Tangen, Catherine M
|b 65
700 1 _ |a Thomas, Duncan C
|b 66
700 1 _ |a Tian, Yu
|0 P:(DE-He78)834e8bc4d74592e3b999100c157215f5
|b 67
700 1 _ |a Um, Caroline Y
|b 68
700 1 _ |a van Duijnhoven, Franzel Jb
|b 69
700 1 _ |a Van Guelpen, Bethany
|b 70
700 1 _ |a Visvanathan, Kala
|b 71
700 1 _ |a Wang, Jun
|b 72
700 1 _ |a White, Emily
|b 73
700 1 _ |a Wolk, Alicja
|b 74
700 1 _ |a Woods, Michael O
|b 75
700 1 _ |a Ulrich, Cornelia M
|b 76
700 1 _ |a Hsu, Li
|b 77
700 1 _ |a Gauderman, W James
|b 78
700 1 _ |a Peters, Ulrike
|b 79
700 1 _ |a Tsilidis, Konstantinos K
|b 80
773 _ _ |a 10.1016/j.ajcnut.2023.08.010
|g p. S0002916523661088
|0 PERI:(DE-600)1496439-9
|n 5
|p 881-891
|t The American journal of clinical nutrition
|v 118
|y 2023
|x 0095-9871
909 C O |p VDB
|o oai:inrepo02.dkfz.de:282365
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 67
|6 P:(DE-He78)834e8bc4d74592e3b999100c157215f5
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-03-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b AM J CLIN NUTR : 2022
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b AM J CLIN NUTR : 2022
|d 2023-10-21
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21